Clinical Trial Application (IND) for BioRay Pharmaceutical’s BR105 Injection Receives U.S. FDA Approval
(Adnkronos) – SHANGHAI, Oct. 24, 2023 /PRNewswire/ — BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as “BioRay”) announced on October 7th that its clinical trial application for BR105 Injection has received approval
